What is Surterra?
Headquartered in Atlanta, Georgia, Surterra Wellness operates as a sophisticated, vertically integrated enterprise within the cannabis industry. The company distinguishes itself through a comprehensive portfolio of brands designed to address the diverse needs of patients seeking natural therapeutic alternatives. Their product ecosystem is expansive, featuring vaporizer pens, tinctures, oral sprays, topical creams, time-released transdermal patches, and soft gels.
By controlling the supply chain from cultivation to retail, Surterra Wellness ensures rigorous quality control and product consistency. This operational model has allowed the company to establish a formidable market position, effectively bridging the gap between traditional pharmaceutical-grade standards and the growing consumer demand for holistic, plant-based wellness products. Their strategic focus on multiple delivery modalities serves as a key differentiator in a competitive and rapidly maturing market.
How much funding has Surterra raised?
Surterra has raised a total of $215.3M across 6 funding rounds:
Multiple Rounds
$40.3M
Series C
$65M
Series D
$100M
Debt
$10M
Private Equity (2016): $15M, investors not publicly disclosed
Series B (2016): $10.3M, investors not publicly disclosed
Series A (2016): $15M, investors not publicly disclosed
Series C (2018): $65M featuring Wrigley
Series D (2019): $100M, investors not publicly disclosed
Debt (2022): $10M with participation from Sunstream
Key Investors in Surterra
Sunstream
Sunstream is a leader in hydraulic marine engineering and advanced lift systems, bringing a focus on precision design and mechanical innovation to its investment portfolio.
Wrigley
A strategic investor with a focus on long-term capital growth and market expansion within the consumer goods and wellness sectors.
Undisclosed Investor
An institutional partner providing essential debt financing to support the ongoing operational scaling and infrastructure development of the company.
What's next for Surterra?
With the recent infusion of capital, Surterra Wellness is poised to accelerate its strategic growth initiatives. The company is expected to leverage these resources to optimize its vertical operations and potentially expand its reach into emerging jurisdictions. As the regulatory environment for medical cannabis continues to shift, the firm's ability to maintain its enterprise-level infrastructure will be critical to sustaining its competitive advantage.
Future developments will likely focus on enhancing R&D capabilities to refine existing delivery systems and potentially introducing new, innovative wellness products. By maintaining a focus on operational excellence and market-specific compliance, Surterra Wellness is well-equipped to solidify its leadership in the medical cannabis sector, ensuring long-term value creation for its stakeholders and continued access for its patient base.
